PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32583961-7	2021	Obeticholic acid showed reduction of fibrosis in adults with NASH taking 25mg daily for 18 months (n=931, reduction in fibrosis in 25% vs. 12% placebo, p<0.01).	obeticholic acid	0-16	SAM domain, SH3 domain and nuclear localization signals 1	Homo sapiens	61-65	
31919473-0	2020	Obeticholic acid for the treatment of NASH.	obeticholic acid	0-16	SAM domain, SH3 domain and nuclear localization signals 1	Homo sapiens	38-42	
31813639-0	2019	Obeticholic acid: towards first approval for NASH.	obeticholic acid	0-16	SAM domain, SH3 domain and nuclear localization signals 1	Homo sapiens	45-49	
29512910-0	2018	Editorial: weight change, liver histology and the metabolic effects of obeticholic acid in NASH.	obeticholic acid	71-87	SAM domain, SH3 domain and nuclear localization signals 1	Homo sapiens	91-95	
25864227-0	2015	Obeticholic acid: expanding the therapeutic landscape of NASH.	obeticholic acid	0-16	SAM domain, SH3 domain and nuclear localization signals 1	Homo sapiens	57-61	
26114083-7	2015	The farnesoid X nuclear receptor (FXR) has been demonstrated to have important metabolic effects and its pharmacological activation by obeticholic acid has been recently reported to produce histological improvement in NASH.	obeticholic acid	135-151	SAM domain, SH3 domain and nuclear localization signals 1	Homo sapiens	218-222